Recent Reports


2010-01-25: Medical Research, Diagnostic Substances, Life Science Tools Report
7 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 35 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Consumer Health Services Report
7 leading Analysts; and top management from 2 Sector Firm examine this vital industry in this 53 page report from The Wall Street Transcript.
More Information
Order this Report

2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

2009-10-19: Biotechnology Report
3 leading Analysts; 2 Money Managers; and top management from 12 Sector Firms examine this vital industry in this 70 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Real Estate: Healthcare REITs, Long-Term Care Facilities & Hospitals Report
3 analysts and 6 sector firms examine the medical real estate segment in this 45 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Devices Report
4 analysts and 7 sector firms examine the medical devices segment in this 41 page report from The Wall Street Transcript.
More Information
Order this Report

09.14.09: Medical Research Services Report
2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
WAYNE SMITH - COMMUNITY HEALTH SYSTEMS INC (CYH)


Full article published: 09/20/2000


For Subscribers

Get this article online now!

Order just this article
TWST: Could you start by giving us a brief overview and profile of Community Health Systems?
Mr. Smith: Community Health Systems was founded in 1985, went public in 1991 at $8/share and then was acquired in an LBO by Forstmann Little & Co., Ted Forstmann's company, for $52/share in the summer of 1996. I was recruited by Forstmann Little and arrived here in January 1997. We currently have 51 facilities in 20 states. In 84% of our markets, we're the sole provider in those communities. Last year, we had revenues in excess of $1 billion and EBITDA over $200 million. From 1997 to 1999, we had about 21% revenue growth, compounded annually, and a 29% EBITDA growth, and we improved our margins about 2.4% during this same period. We just released our second-quarter earnings, and net revenues for the quarter ending June 30, 2000 totaled $317.1 million, a 21.1% increase over the prior year. Adjusted EBITDA for the second quarter of 2000 was $59.8 million, a 19.6% increase over the prior year. Net income was $0.2 million compared with $1.8 million loss for the second quarter last year. Same hospital net revenues increased by 10.5% with admissions up 7.8% versus second quarter of last year. We also improved our same hospital adjusted EBITDA margin to 19.9% from 19.1% in the second quarter of last year.

TWST: The hospital market has been in trouble lately. How have you guys done so well?
Mr. Smith: We're in the non-urban markets, which we believe to be the most attractive sector in healthcare. We think the non-urban markets obviously offer great opportunities for us because there's little or no competition; the markets represent about 25% of the US population and have underserved healthcare needs. As I said earlier, in about 84% of our markets, we're the sole provider. We have very limited managed care. The demographics are really good in the smaller markets in that there's a growing population of Medicare in those markets. The economy is generally good in the communities where we operate because of diverse industry. So we've focused on non-urban markets that meet our criteria, and we have implemented a standardized and centralized operating model, which works well for us.

 

Tickers included in this excerpt: CYH

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.